ResultsIQ › Latest results › Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited Q2 FY27 results deck summary
NSE: GAUDIUMIVF · BSE: 544709
Results deck of 15 Nov 2026, summarised by AI from the filing.
Consolidated EBITDA margin was 36.00% (Q2 FY26: 43.37%) and PAT margin 25.16% (Q2 FY26: 29.56%) on new-hub costs.
Key takeaways
- Margin pressure Consolidated EBITDA margin was 36.00% (Q2 FY26: 43.37%) and PAT margin 25.16% (Q2 FY26: 29.56%) on new-hub costs.
- Sequential rebound Consolidated revenue rose to ₹3,741.11 lakh in Q2 FY27 from ₹1,937.66 lakh in Q1 FY27, and PAT to ₹941.31 lakh from ₹177.59 lakh.
- Expansion South Delhi and Gurgaon hubs were inaugurated in FY27, Nagpur is launching soon, and seven upcoming hubs are planned for FY27.
- Licence risk The South Delhi Hub centre is ready but its licence approval is still awaited.
Gaudium IVF and Women Health Limited Q2 FY27 results
As filed: Revenue ₹37.4 cr, EBITDA ₹13.5 cr, PAT ₹9.4 cr, EBITDA margin 36.0%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹37.4 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹19.4 cr, EBITDA ₹2.4 cr, PAT ₹1.8 cr, EBITDA margin 12.5%. Not scored. Too small to score: quarter revenue ₹19.4 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −6.4% in 29 days (Nifty 500: −3.3%).
- Q4 FY26: Revenue ₹30.4 cr, EBITDA ₹12.2 cr, PAT ₹8.4 cr, EBITDA margin 40.1%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.4 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −7.0% in 28 days (Nifty 500: +0.6%).
- Q3 FY26: Revenue ₹24.5 cr, EBITDA ₹6.6 cr, PAT ₹3.6 cr, EBITDA margin 26.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹24.5 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +2.2% in 30 days (Nifty 500: +4.3%).
Past price moves after results do not indicate future moves. Not a recommendation.
Gaudium IVF and Women Health Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (15 Nov 2026), Results press release (12 Nov 2026)
- Q1 FY27: Earnings call (14 Aug 2026), Results deck (13 Aug 2026), Results deck (14 Aug 2026), Results press release (13 Aug 2026)
- Q4 FY26: Results deck (29 May 2026), Results press release (28 May 2026)
- Q3 FY26: Results press release (19 Mar 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.